 |
28 Diseases |  |
11 Trials |
|
11 Trials |  |
282 News |  |
| «123456 |
- | Levovir (clevudine) / Bukwang Pharma, Eisai
New P1 trial: A Clinical Trial to Investigate the Pharmacokinetic Drug-drug Interaction of Clevudine and Adefovir Dipivoxil After Oral Administration in Healthy Male Subjects (clinicaltrials.gov) - Apr 18, 2012
P1, N=42, Completed, Sponsor: Bukwang Pharmaceutical
- prednisone / Generic mfg., adefovir dipivoxil / Generic mfg.
Trial withdrawal: Efficacy Study of Prednisone Priming to Treat Asian Chronic Hepatitis B Patients (clinicaltrials.gov) - Apr 17, 2012
P=N/A, N=0, Withdrawn, Sponsor: Maimonides Medical Center
Active, not recruiting --> Withdrawn
- prednisone / Generic mfg., adefovir dipivoxil / Generic mfg.
Enrollment change: Efficacy Study of Prednisone Priming to Treat Asian Chronic Hepatitis B Patients (clinicaltrials.gov) - Apr 17, 2012
P=N/A, N=0, Withdrawn, Sponsor: Maimonides Medical Center
Active, not recruiting --> Withdrawn N=40 --> 0
- Enrollment change: A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV (clinicaltrials.gov) - Apr 5, 2012
P2, N=90, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
N=40 --> 0 N=53 --> 90
- ||| Pegasys (pegylated interferon α -2a) / Roche
Enrollment change: A Study of Peginterferon Alfa-2a [PEGASYS] in Patients With Chronic Hepatitis B Who Are HBeAg Positive (clinicaltrials.gov) - Mar 13, 2012
P4, N=265, Completed, Sponsor: Hoffmann-La Roche
N=53 --> 90 N=176 --> 265
- | adefovir dipivoxil / Generic mfg.
New P4 trial, Combination therapy: Switch From Adefovir to Tenofovir in Chronic Hepatitis B for Suboptimal Response to Adefovir-based Combination Therapy (clinicaltrials.gov) - Mar 10, 2012
P4, N=124, Recruiting, Sponsor: Yonsei University
- | New P4 trial, Combination therapy: Adefovir and Lamivudine for Entecavir Resistance (ALTER Study) (clinicaltrials.gov) - Mar 5, 2012
P4, N=20, Completed, Sponsor: Korea University
- ||| Pegasys (pegylated interferon ? -2a) / Roche, Roferon A (recombinant interferon alfa-2a) / Roche
Trial initiation date: PAS: PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients (clinicaltrials.gov) - Feb 9, 2012
P4, N=90, Recruiting, Sponsor: Foundation for Liver Research
N=176 --> 265 Initiation date: Oct 2011 --> Mar 2012
- | Tyzeka (telbivudine) / Novartis
New P4 trial: STEN: A Two-year Study of Telbivudine in HBeAg Negative Hepatitis (clinicaltrials.gov) - Jan 25, 2012
P4, N=360, Recruiting, Sponsor: Third Affiliated Hospital, Sun Yat-Sen University
- | lamivudine HBV / Generic mfg., lamivudine / Generic mfg., adefovir dipivoxil / Generic mfg.
New P4 trial: Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients (clinicaltrials.gov) - Dec 11, 2011
P4, N=160, Recruiting, Sponsor: Taipei Veterans General Hospital, Taiwan
- ||||| tenofovir disoproxil fumarate / Generic mfg., adefovir dipivoxil / Generic mfg.
Enrollment closed: Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) 300mg in Chinese Subjects With Chronic Hepatitis B (CHB) (clinicaltrials.gov) - Dec 1, 2011
P3, N=512, Active, not recruiting, Sponsor: GlaxoSmithKline
Initiation date: Oct 2011 --> Mar 2012 Recruiting --> Active, not recruiting
- | lamivudine HBV / Generic mfg., adefovir dipivoxil / Generic mfg.
New P4 trial: CLINICAL TRIAL WITH TENOFOVIR VERSUS LAMIVUDINE PLUS ADEFOVIR DIPIVOXIL IN LAMIVUDINE-RESISTANT CHRONIC HEPATITIS-B PATIENTS WITH UNDETECTABLE VIRAL LOAD ENSAYO CLÍNICO DE SIMPLIFICACIÓN CON TENOFOVIR EN PACIENTES CON HEPATITIS CRÓNICA B RESISTENTES A LAMIVUDINA Y CARGA VIRAL INDETECTABLE EN TRATAMIENTO CON LAMIVUDINA MÁS ADEFOVIR DIPIVOXIL (Estudio TENOSIMP-B) (EUDRACT) - Nov 2, 2011
P4, N=100, Ongoing, Sponsor: Manuel Rodríguez García
- |||| adefovir dipivoxil / Generic mfg.
Trial completion, Combination therapy, Monotherapy: Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil (clinicaltrials.gov) - Oct 30, 2011
P2, N=106, Completed, Sponsor: Gilead Sciences
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Pegasys (pegylated interferon α -2a) / Roche
Trial completion, Monotherapy: ADVANCE Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) + Adefovir Dipivoxil in Patients With Hbe(-) Chronic Hepatitis B (clinicaltrials.gov) - Sep 18, 2011
P3, N=10, Completed, Sponsor: Hoffmann-La Roche
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | adefovir dipivoxil / Generic mfg.
New P4 trial: Study of Effects and Safety Between Adefovir Dipivoxil Plus Polyene Phosphatidylcholine Versus Adefovir Dipivoxil Alone in Chronic Hepatitis B Patients (clinicaltrials.gov) - Sep 12, 2011
P4, N=300, Not yet recruiting, Sponsor: Jun Cheng